Immunogen reported $481.71M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Amgen AMGN:US $ 59196M 1969M
Astellas Pharma 4503:JP Y 2332395M 23850M
AstraZeneca AZN:LN 100273M 5090M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Emergent Biosolutions EBS:US $ 2780.4M 178.6M
Exelixis EXEL:US $ 2654.12M 37.88M
Halozyme Therapeutics HALO:US $ 1162.25M 57.82M
Heron Therapeutics HRTX:US $ 273.72M 31.98M
Immunogen IMGN:US $ 481.71M 44.06M
Intrexon XON:US $ 335.57M 24.29M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Macrogenics MGNX:US $ 271.44M 63.8M
Nektar Therapeutics NKTR:US $ 1024.12M 93.07M
Novartis NVS:US $ 125218M 6577M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Seattle Genetics SGEN:US $ 3616.69M 102.91M